Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Adverum Biotechnologies Inc (ADVM)

  • SEC News
  • Dec. 10, 2025, 18:34 UTC
  • 0
  • 1 comments

Tuckson Reed Vaughn 🔴 sold 33.5K shares (5 derivative) of Adverum Biotechnologies, Inc. (ADVM) at $128.50 Transaction Date: Dec 09, 2025 | Filing ID: 000005

Comment Full text

Adverum Biotechnologies Inc (ADVM)

  • SEC News
  • Dec. 10, 2025, 18:31 UTC
  • 0
  • 1 comments

Svoronos Dawn 🔴 sold 42.5K shares (6 derivative) of Adverum Biotechnologies, Inc. (ADVM) at $128.20 Transaction Date: Dec 09, 2025 | Filing ID: 000004

Comment Full text

Adverum Biotechnologies Inc (ADVM)

  • SEC News
  • Dec. 10, 2025, 18:29 UTC
  • 0
  • 1 comments

Scopa James Paul 🔴 sold 55.5K shares (8 derivative) of Adverum Biotechnologies, Inc. (ADVM) at $256.40 ($2.0M) Transaction Date: Dec 09, 2025 | Filing ID: 000004

Comment Full text

Adverum Biotechnologies Inc (ADVM)

  • SEC News
  • Dec. 10, 2025, 18:27 UTC
  • 0
  • 1 comments

Nicholson, C. David 🔴 sold 29.0K shares (3 derivative) of Adverum Biotechnologies, Inc. (ADVM) at $9.31 Transaction Date: Dec 09, 2025 | Filing ID: 000003

Comment Full text

Adverum Biotechnologies Inc (ADVM)

  • SEC News
  • Dec. 10, 2025, 18:25 UTC
  • 0
  • 1 comments

Lupher, Jr. Mark L. 🔴 sold 60.5K shares (8 derivative) of Adverum Biotechnologies, Inc. (ADVM) at $256.40 ($2.2M) Transaction Date: Dec 09, 2025 | Filing ID: 000004

Comment Full text

Adverum Biotechnologies Inc (ADVM)

  • SEC News
  • Dec. 10, 2025, 18:22 UTC
  • 0
  • 1 comments

Machado Patrick 🔴 sold 75.3K shares (12 derivative) of Adverum Biotechnologies, Inc. (ADVM) at $256.40 ($2.6M) Transaction Date: Dec 09, 2025 | Filing ID: 000004

Comment Full text

Adverum Biotechnologies Inc (ADVM)

  • SEC News
  • Dec. 10, 2025, 18:05 UTC
  • 0
  • 1 comments

Kiss Szilard 🔴 sold 52.2K shares (8 derivative) of Adverum Biotechnologies, Inc. (ADVM) at $94.50 ($1.3M) Transaction Date: Dec 09, 2025 | Filing ID: 000004

Comment Full text

AIRTOUCH (ARTS)

  • Technical Exchange News
  • Dec. 10, 2025, 17:50 UTC
  • 2
  • 0 comments

AIRTOUCH (ARTS) was removed from the list of traded instruments on TASE exchange

Comment Full text

Azenta Inc (AZTA)

  • SEC News
  • Dec. 10, 2025, 17:45 UTC
  • 0
  • 1 comments

(99% Neutral) Azenta, Inc. (AZTA) Announces Business Combination

Comment Full text

Azenta Inc (AZTA)

  • Business News
  • Dec. 10, 2025, 17:43 UTC
  • 1
  • 1 comments

Azenta Authorizes $250 Million Share Repurchase Program

Market reaction Comment Full text

EPAM Systems Inc. (EPAM)

  • SEC News
  • Dec. 10, 2025, 17:37 UTC
  • 1
  • 1 comments

📋 Boris Shnayder (Officer) plans to sell 5K shares of EPAM Systems, Inc. (at $207.00 each, total $1.0M) Filed: Dec 10, 2025 | ID: 001062

Comment Full text

Kintara Therapeutics Inc. (KTRA)

  • SEC News
  • Dec. 10, 2025, 17:02 UTC
  • 0
  • 0 comments

New Form 424B5 - TuHURA Biosciences, Inc./NV Filed: 2025-12-10 AccNo: 0001193125-25-313799 Size: 663 KB

Comment Full text

GENFIT S.A. (GNFT)

  • Business News
  • Dec. 10, 2025, 17:00 UTC
  • 0
  • 1 comments

GENFIT: GNS561 Shows Promising Antitumor Activity in Combination Therapy

Market reaction Comment Full text

Perrigo Company plc (PRGO)

  • Business News
  • Dec. 10, 2025, 17:00 UTC
  • 0
  • 1 comments

Perrigo Company plc (PRGO) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

Market reaction Comment Full text

Baxter International Inc (BAX)

  • Business News
  • Dec. 10, 2025, 17:00 UTC
  • 0
  • 1 comments

Baxter International, Inc. (BAX) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

Market reaction Comment Full text
  • Previous
  • 69
  • 70
  • 71
  • 72
  • 73
  • Next

Search

News categories

  • Technical Exchange News(10564)
  • Event(1910)
  • SEC News(183281)
  • FDA Approval(9799)
  • Company Report(721)
  • Business News(121540)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin